SCHEMBL29567271

SCHEMBL29567271

O=S(=O)(Nc1nc(Cl)c(-c2ccccc2)c(-c2ccccc2)n1)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.50
NPSR1 Q6W5P4 2/20 0.48
KDM4E B2RXH2 1/20 0.48
RXFP1 Q9HBX9 1/20 0.48
PIK3CD O00329 2/20 0.47
MAPT P10636 1/20 0.47
PIK3CA P42336 1/20 0.47
PIK3CB P42338 1/20 0.47
PIK3CG P48736 1/20 0.47
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
KDM1A O60341 3/20 0.43
GAA P10253 2/20 0.43
PKM P14618 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
HSD11B1 P28845 1/20 0.43
POLB P06746 1/20 0.41
SLC40A1 Q9NP59 1/20 0.41
LMNA P02545 1/20 0.41
IL1RN P18510 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309359 1.00 TSHR (0.50) TSHRNPSR1KDM4ERXFP1PIK3CD
SCHEMBL24309362 0.79 PGR (0.47) TSHRNPSR1KDM4EMAPTMEN1
SCHEMBL29567205 0.79 PGR (0.47) TSHRNPSR1KDM4EMAPTMEN1
SCHEMBL24310041 0.78 TSHR (0.58) TSHRNPSR1KDM4EMAPTMEN1
SCHEMBL24309401 0.77 TSHR (0.66) TSHRNPSR1KDM4ERXFP1MEN1
SCHEMBL24310050 0.75 TSHR (0.59) TSHRNPSR1KDM4EMAPTGAA
SCHEMBL10643363 0.75 TSHR (0.62) TSHRNPSR1KDM4ERXFP1MAPT
SCHEMBL26812357 0.75 EDNRA (0.47) TSHRNPSR1KDM4EMAPTMEN1
SCHEMBL24310040 0.75 TSHR (0.58) TSHRNPSR1KDM4ERXFP1MAPT
SCHEMBL29516515 0.75 KDM4E (0.59) TSHRNPSR1KDM4ERXFP1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 WO disclosed